|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/155 | |
| A61K 31/343 | |||
| A61K 31/36 | |||
| A61K 31/381 | |||
| A61K 31/40 | |||
| A61K 31/341 | |||
| A61K 31/41 | |||
| A61K 31/53 | |||
| A61P 3/00 |
| (11) | Number of the document | 2800561 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12738330.5 |
| Date of filing the European patent application | 2012-07-11 | |
| (97) | Date of publication of the European application | 2014-11-12 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/046335 |
| Date | 2012-07-11 |
| (87) | Number | WO 2013/103384 |
| Date | 2013-07-11 |
| (30) | Number | Date | Country code |
| PCT/US2012/0205 | 2012-01-06 | WO | |
| 201213345135 | 2012-01-06 | US | |
| 201261649171 P | 2012-05-18 | US |
| (72) |
BARON, Alain, D., US
FINEMAN, Mark, S., US
BEELEY, Nigel, R. A., US
|
| (73) |
Anji Pharma (US) LLC,
4 Dana Road, Boxford, MA 01921,
US
|
| (54) | BIGUANIDE COMPOSITIONS AND METHODS OF TREATING METABOLIC DISORDERS |
| BIGUANIDE COMPOSITIONS AND METHODS OF TREATING METABOLIC DISORDERS |